Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2014, Article ID 954671, 6 pages
http://dx.doi.org/10.1155/2014/954671
Research Article

DDIT3 Expression in Liposarcoma Development

1Sahlgrenska Cancer Center, Department of Pathology, Institute of Biomedicine, University of Gothenburg, P.O. Box 425, 40530 Gothenburg, Sweden
2Department of Oncology, Institute of Medical Sciences, University of Gothenburg, Gothenburg, Sweden

Received 5 December 2013; Accepted 13 February 2014; Published 25 March 2014

Academic Editor: Enrique de Alava

Copyright © 2014 Christina Kåbjörn Gustafsson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [3 citations]

The following is the list of published articles that have cited the current article.

  • Pierre Åman, Soheila Dolatabadi, David Svec, Emma Jonasson, Setareh Safavi, Daniel Andersson, Pernilla Grundevik, Christer Thomsen, and Anders Ståhlberg, “ Regulatory mechanisms, expression levels and proliferation effects of the FUS-DDIT3 fusion oncogene in liposarcoma ,” The Journal of Pathology, vol. 238, no. 5, pp. 689–699, 2016. View at Publisher · View at Google Scholar
  • Lauren T. Kerr, Jacqueline F. Donoghue, Alexander L. Wilding, and Terrance G. Johns, “Axitinib Has Antiangiogenic and Antitumorigenic Activity in Myxoid Liposarcoma,” Sarcoma, vol. 2016, pp. 1–17, 2016. View at Publisher · View at Google Scholar
  • Xuwei Jiang, and Yuqing Hao, “Analysis of expression profile data identifies key genes and pathways in hepatocellular carcinoma,” Oncology Letters, vol. 15, no. 2, pp. 2625–2630, 2018. View at Publisher · View at Google Scholar